Because the increasing prevalence of atrial fibrillation imposes significant financial and clinical burdens, efficient healthcare delivery is required to improve outcomes and reduce associated costs.
Matthew R. Reynolds, MD, MSc
Advertisement
Articles by Matthew R. Reynolds, MD, MSc
Advertisement
Latest Updated Articles
- Economic Burden of Atrial Fibrillation: Implications for Intervention
Published: April 4th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Therapeutic Cancer Vaccines: Are We There Yet?
2
FDA Approves Gazyva for Active Lupus Nephritis
3
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
4
Walgreens Strengthens Vaccine Access Through Digital Tools, Pharmacist Education
5
